And if we can add other lipid tests for other cancers ?We are...

And if we can add other lipid tests for other cancers ?
We are talking a valuation curve into multiple billions imo.

Is CSL a likely predator who would want to acquire us. ?
Even for just the $$$$ that will flow globally from the breast tests ?
Yet alone the wheel barrows of gold that can flow from other cancer tests ?

Big companies like CSL, need to think about what whale they swallow, to be significant to their earnings growth.

CSL has a 135 billion MC.

Now think about us globally doing say 100m tests per year,,,???take a wild guess at the global profit margins that flows back to us. And we are a bet on billion dollar multiple earnings profit machine. What when we add other cancer types ?
Thats what a CSL or other predator has to consider for how much it might take us over for. The further up the earnings growth mountain we climb, the more validated our growth profit trajectory will become.

But speculative markets are about picking winners and losers early, and as well simply backing that there is a market discovery stage, that in concept alone, can re-rate in the small caps to mid caps well before the larger stakes are paid out.

Spec markets like big carrots. x perception of moderate execution risk

Not investment advice.
Gamble responsibly.